{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:05:09Z","timestamp":1791108309337,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T00:00:00Z","timestamp":1670198400000},"content-version":"vor","delay-in-days":4325,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1111\/j.1600-6143.2010.03400.x","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T13:30:31Z","timestamp":1294666231000},"page":"196-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients"],"prefix":"10.1016","volume":"11","author":[{"given":"S.C.","family":"Jordan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Kahwaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.A.","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2010.03400.x_bib1","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.immunol.26.021607.090232","article-title":"Anti-inflammatory actions of intravenous immunoglobulin","volume":"26","author":"Nimmerjahn","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.autrev.2006.03.010","article-title":"Common variable immune deficiency and autoimmunity","volume":"5","author":"Brandt","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181a9e89a","article-title":"Intravenous immunoglobulin a natural regulator of immunity and inflammation","volume":"88","author":"Jordan","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2249.2009.04022.x","article-title":"Intravenous Immunoglobulians\u2014Understanding Properties and Mechanisms","volume":"158","author":"Durandy","year":"2009","journal-title":"Clin Exp. Immunology"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00007890-199809270-00017","article-title":"Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action","volume":"66","author":"Jordan","year":"1998","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00007890-200101150-00009","article-title":"A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection","volume":"71","author":"Casadei","year":"2001","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib7","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-009-1386-4","article-title":"Advances in diagnosis and managing antibody-mediated rejection","volume":"25","author":"Jordan","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib8","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1097\/01.ASN.0000145878.92906.9F","article-title":"Evaluation of intravenous immunoglobulin as an agent to lower allosensitization and improve transplantation in highly-HLA sensitized adult patients with end stage renal disease: Report of the NIH IG02 trial","volume":"15","author":"Jordan","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib9","doi-asserted-by":"crossref","unstructured":"United Network for Organ Sharing (UNOS) (unos.org). August 7, 2010.","DOI":"10.1053\/j.ajkd.2010.04.004"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/00007890-200009270-00006","article-title":"Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients","volume":"70","author":"Montgomery","year":"2000","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tmrv.2009.09.010","article-title":"The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence -based practice guideline","volume":"24","author":"Shehata","year":"2010","journal-title":"Transf Med Rev"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tmrv.2009.09.009","article-title":"Guidelines for the use of immunoglobulin therapy for primary immune deficiency and solid organ transplantation","volume":"24","author":"Nahirniak","year":"2010","journal-title":"Transfus Med Rev"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib13","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1097\/00007890-199612150-00024","article-title":"Long-term benefit of intravenous immunoglobulins in cadaveric kidney retransplantation","volume":"62","author":"Peraldi","year":"1996","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib14","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/TP.0b013e3181af3914","article-title":"Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin","volume":"88","author":"Mai","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib15","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1600-6143.2010.03093.x","article-title":"Efficacy of induction therapy with ATG and intravenous immunoglobulin in patients with low-level donor specific HLA antibodies","volume":"10","author":"Bachler","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/TP.0b013e3181919a16","article-title":"Living donor kidney transplantation across positive crossmatch: The university of illinois at chicago experience","volume":"87","author":"Thielke","year":"2009","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib17","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/TP.0b013e318176ae2c","article-title":"Renal transplantation in patients with positive lymphocytotoxicity crossmatches: One center\u2019s experience","volume":"86","author":"Magee","year":"2008","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa0707894","article-title":"Rituximab and Intravenous immune globulin for desensitization during renal transplantation","volume":"359","author":"Vo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib19","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/TP.0b013e3181d21e7f","article-title":"Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation","volume":"89","author":"Vo","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib20","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: A pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.autrev.2008.04.001","article-title":"Intravenous immunoglobulin-indications and mechanisms in cardiovascular disease","volume":"7","author":"Udl","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib22","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","article-title":"Plasma-pheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation","volume":"18","author":"Pisani","year":"1999","journal-title":"J Heart Lung Transplant"},{"issue":"19 Suppl","key":"10.1111\/j.1600-6143.2010.03400.x_bib23","first-page":"II229","article-title":"Intravenous immuno-globulin reduces anti-HLA alloreactivity and shortens waiting time to cardiac transplantation in highly sensitized left ventricular assist device recipients","volume":"100","author":"John","year":"1999","journal-title":"Circulation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.humimm.2005.01.025","article-title":"Utility of peritransplant and rescue intravenous immunoglobulin and extracorporeal immunoadsorption in lung transplant recipients sensitized to HLA antigens","volume":"66","author":"Appel","year":"2005","journal-title":"Hum Immunol"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib25","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.healun.2010.05.006","article-title":"Anti-human leukocyte antigen antibodies and preemptive antibody-directed therapy after lung transplantation","volume":"29","author":"Hachem","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1600-6143.2009.02591.x","article-title":"Comparison of combination plasmapheresis\/IVIG\/Anti-CD20 versus high dose IVIG in the treatment of antibody-mediated rejection","volume":"9","author":"Lefaucher","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib27","first-page":"317","article-title":"Comparison of induction therapy with campath 1H vs Zenapax\u00ae in Highly-HLA Sensitized Patients (HS) transplanted after desensitization With IVIG+Rituximab","volume":"10","author":"Vo","year":"2010","journal-title":"Am J Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1399-0012.2008.00902.x","article-title":"Impact of rituximab therapy for treatment of acute humoral rejection","volume":"23","author":"Kaposztas","year":"2009","journal-title":"Clin Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1111\/j.1600-6143.2009.02711.x","article-title":"Evidence for humoral rejection of a pancreatic islet graft and rescue with rituximab and IV immunoglobulin therapy","volume":"9","author":"Kessler","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MOT.0b013e3283186bbc","article-title":"Hypogammaglobulinemia and infection risk in solid organ transplant recipients","volume":"13","author":"Manhorter","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-3046.2008.01105.x","article-title":"IVIG As treatment for BK virus nephropathy","volume":"13","author":"Smith","year":"2008","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib32","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1600-6143.2003.00647.x","article-title":"Cellular immune response to CMV in renal transplant recipients","volume":"5","author":"Rhada","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib33","article-title":"Long-term remission of recurrent parvovirus B19 infection in a pediatric renal transplant recipient","author":"Shen","year":"2010","journal-title":"Pediatr Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib34","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1034\/j.1600-6143.2002.20505.x","article-title":"Treatment of parvovirus B-19 infection allows for successful kidney transplantation without disease recurrence","volume":"2","author":"Barsoum","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/01.tp.0000229039.87735.76","article-title":"Acute rejection and cardiac allograft vascular disease reduced by suppression of subclinical cytomegalovirus infection","volume":"82","author":"Potena","year":"2006","journal-title":"Transplantation"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib36","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2215\/CJN.01701105","article-title":"Safety and adverse events profiles of IVIG products used for immunomodulation: A single-center experience","volume":"4","author":"Vo","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2010.03400.x_bib37","first-page":"155","article-title":"Acute hemolysis after high dose IVIG therapy in highly HLA sensitized patients","volume":"24","author":"Kahwaji","year":"2009","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2010.03400.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522278058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522278058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2010.03400.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:52:57Z","timestamp":1761627177000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522278058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S1600613522278058"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03400.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Aspects of Intravenous Immunoglobulin Use in Solid Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2010.03400.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}